These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 38803504

  • 1. Corilagin alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation via the Olfr2 signaling pathway in vitro and in vivo.
    Mao J, Chen Y, Zong Q, Liu C, Xie J, Wang Y, Fisher D, Hien NTT, Pronyuk K, Musabaev E, Li Y, Zhao L, Dang Y.
    Front Immunol; 2024; 15():1364161. PubMed ID: 38803504
    [Abstract] [Full Text] [Related]

  • 2. Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome-related inflammation and modulating cholesterol transport.
    Luo J, Wang X, Jiang X, Liu C, Li Y, Han X, Zuo X, Li Y, Li N, Xu Y, Si S.
    FASEB J; 2020 Jan; 34(1):1398-1411. PubMed ID: 31914630
    [Abstract] [Full Text] [Related]

  • 3. Corilagin Restrains NLRP3 Inflammasome Activation and Pyroptosis through the ROS/TXNIP/NLRP3 Pathway to Prevent Inflammation.
    Luo T, Zhou X, Qin M, Lin Y, Lin J, Chen G, Liu A, Ouyang D, Chen D, Pan H.
    Oxid Med Cell Longev; 2022 Jan; 2022():1652244. PubMed ID: 36299604
    [Abstract] [Full Text] [Related]

  • 4. Quercetin Attenuates Atherosclerotic Inflammation by Inhibiting Galectin-3-NLRP3 Signaling Pathway.
    Li H, Xiao L, He H, Zeng H, Liu J, Jiang C, Mei G, Yu J, Chen H, Yao P, Tang Y.
    Mol Nutr Food Res; 2021 Aug; 65(15):e2000746. PubMed ID: 33939881
    [Abstract] [Full Text] [Related]

  • 5. Reactive Oxygen Species-Responsive Nanoparticle Delivery of Small Interfering Ribonucleic Acid Targeting Olfactory Receptor 2 for Atherosclerosis Theranostics.
    Ni H, Zhou H, Liang X, Ge Y, Chen H, Liu J, Wang B, Chen H, Zhang Y, Luo S, Chen Y, Lu X, Yin C, Fan Q.
    ACS Nano; 2024 Aug 27; 18(34):23599-23614. PubMed ID: 39141682
    [Abstract] [Full Text] [Related]

  • 6. Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production.
    Orecchioni M, Kobiyama K, Winkels H, Ghosheh Y, McArdle S, Mikulski Z, Kiosses WB, Fan Z, Wen L, Jung Y, Roy P, Ali AJ, Miyamoto Y, Mangan M, Makings J, Wang Z, Denn A, Vallejo J, Owens M, Durant CP, Braumann S, Mader N, Li L, Matsunami H, Eckmann L, Latz E, Wang Z, Hazen SL, Ley K.
    Science; 2022 Jan 14; 375(6577):214-221. PubMed ID: 35025664
    [Abstract] [Full Text] [Related]

  • 7. Corilagin Ameliorates Atherosclerosis in Peripheral Artery Disease via the Toll-Like Receptor-4 Signaling Pathway in vitro and in vivo.
    Li Y, Wang Y, Chen Y, Wang Y, Zhang S, Liu P, Chen Z, Song P, Luo L, Luo Y, Dang Y, Zhao L.
    Front Immunol; 2020 Jan 14; 11():1611. PubMed ID: 32849545
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. ZeXieYin formula alleviates atherosclerosis by inhibiting the MAPK/NF-κB signaling pathway in APOE-/- mice to attenuate vascular inflammation and increase plaque stability.
    Huang R, Sun Y, Liu R, Zhu B, Zhang H, Wu H.
    J Ethnopharmacol; 2024 Jun 12; 327():117969. PubMed ID: 38437888
    [Abstract] [Full Text] [Related]

  • 10. GP73 enhances the ox-LDL-induced inflammatory response in THP-1 derived macrophages via affecting NLRP3 inflammasome signaling.
    Lin YF, Li MH, Huang RH, Zhang SZ, Xu XF, Zhou HM, Liu MH, Liao XX, Liao LZ, Guo Y, Zhuang XD.
    Int J Cardiol; 2023 Sep 15; 387():131109. PubMed ID: 37271284
    [Abstract] [Full Text] [Related]

  • 11. Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis.
    Chen S, Wang Y, Pan Y, Liu Y, Zheng S, Ding K, Mu K, Yuan Y, Li Z, Song H, Jin Y, Fu J.
    J Am Heart Assoc; 2020 Jun 16; 9(12):e015513. PubMed ID: 32476536
    [Abstract] [Full Text] [Related]

  • 12. Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice.
    Wang R, Wang Y, Mu N, Lou X, Li W, Chen Y, Fan D, Tan H.
    Lab Invest; 2017 Aug 16; 97(8):922-934. PubMed ID: 28394319
    [Abstract] [Full Text] [Related]

  • 13. Peperomin E (PepE) protects against high fat diet-induced atherosclerosis in Apolipoprotein E deficient (ApoE-/-) mice through reducing inflammation via the suppression of NLRP3 signaling pathway.
    Yan J, Li M, Wang XD, Lu ZY, Ni XL.
    Biomed Pharmacother; 2018 Sep 16; 105():862-869. PubMed ID: 30021379
    [Abstract] [Full Text] [Related]

  • 14. Guizhitongluo Tablet inhibits atherosclerosis and foam cell formation through regulating Piezo1/NLRP3 mediated macrophage pyroptosis.
    Pan X, Xu H, Ding Z, Luo S, Li Z, Wan R, Jiang J, Chen X, Liu S, Chen Z, Chen X, He B, Deng M, Zhu X, Xian S, Li J, Wang L, Fang H.
    Phytomedicine; 2024 Sep 16; 132():155827. PubMed ID: 38955059
    [Abstract] [Full Text] [Related]

  • 15. Corilagin ameliorates atherosclerosis by regulating MMP-1, -2, and -9 expression in vitro and in vivo.
    Tao Y, Zhang L, Yang R, Yang Y, Jin H, Zhang X, Hu Q, He B, Shen Z, Chen P.
    Eur J Pharmacol; 2021 Sep 05; 906():174200. PubMed ID: 34062170
    [Abstract] [Full Text] [Related]

  • 16. Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation.
    Wen J, Chang Y, Huo S, Li W, Huang H, Gao Y, Lin H, Zhang J, Zhang Y, Zuo Y, Cao X, Zhong F.
    Aging (Albany NY); 2020 Nov 16; 13(1):910-932. PubMed ID: 33290264
    [Abstract] [Full Text] [Related]

  • 17. Fucoidan Inhibits NLRP3 Inflammasome Activation by Enhancing p62/SQSTM1-Dependent Selective Autophagy to Alleviate Atherosclerosis.
    Cheng Y, Pan X, Wang J, Li X, Yang S, Yin R, Ma A, Zhu X.
    Oxid Med Cell Longev; 2020 Nov 16; 2020():3186306. PubMed ID: 33505579
    [Abstract] [Full Text] [Related]

  • 18. Corilagin relieves atherosclerosis via the toll-like receptor 4 signaling pathway in vascular smooth muscle cells.
    Wang Y, Li Y, Chen Y, Mao J, Ji J, Zhang S, Liu P, Pronyuk K, Fisher D, Dang Y, Zhao L.
    Int J Immunopathol Pharmacol; 2024 Nov 16; 38():3946320241254083. PubMed ID: 38869980
    [Abstract] [Full Text] [Related]

  • 19. Integrating network pharmacology and experimental models to identify notoginsenoside R1 ameliorates atherosclerosis by inhibiting macrophage NLRP3 inflammasome activation.
    Yu J, Hu J, Baldini M, Lei H, Li L, Luo S, Wu J, Liu X, Shan D, Xie Y, Fang H, Yu J.
    J Nat Med; 2024 Jun 16; 78(3):644-654. PubMed ID: 38409483
    [Abstract] [Full Text] [Related]

  • 20. Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition.
    Ma S, Chen J, Feng J, Zhang R, Fan M, Han D, Li X, Li C, Ren J, Wang Y, Cao F.
    Oxid Med Cell Longev; 2018 Jun 16; 2018():9286458. PubMed ID: 30254716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.